Antibody Molecules

The most remarkable feature of the antibody molecule is revealed by comparing the amino acid sequences from many different immunoglobulin IgG molecules. This comparison shows that between different IgGs the amino-terminal domain of each polypeptide chain is highly variable, whereas the remaining domains have constant sequences. A light chain is thus built up from one amino-terminal variable domain (Vl) and one carboxy-terminal constant domain (Cl), and a heavy chain from one amino-terminal variable domain (Vh), followed by three constant domains (Chi, Ch2. and Chs). 

IgG antibody molecules are composed of two light chains and two heavy chains joined together by disulfide bonds. Each light chain has one variable domain and one constant domain, while each heavy chain has one variable and three constant domains. All of the domains have a similar three-dimensional structure known as the immunoglobulin fold. The Fc stem of the molecule is formed by constant domains from each of the heavy chains, while two Fab arms are formed by constant and variable domains from both heavy and light chains. The hinge region between the stem and the arms is flexible and allows the arms to move relative to each other and to the stem. 

Biologicals. Figure 3 Fusion protein construction combination of the molecular component of interest with the constant region (Fc) of an antibody molecule, usually immunoglobulin (lg)G1 Fc, imparts the Fc function on to the molecularcomponentfortherapeutic use. The example given is ofCTLA4-lg, derivatives of which have shown clinical efficacy in the treatment of rheumatoid arthritis and transplant rejection. 

Other sensor applications can be considered if some sensitive biological molecules (such as antibodies or receptors) are attached to the nanogranule. If, for example, an antibody molecule is attached to it, then the granule is placed between two electrodes, and single-electron current flows between them. The step value of the coulomb staircase depends on the capacity of the junctions. When the antibody molecule binds specific antigen, the capacity value will be changed, and, therefore, the step value of the VH characteristics will also change. 

The sensitivity of enzyme assays can also be exploited to detect proteins that lack catalytic activity. Enzyme-linked immunoassays (ELlSAs) use antibodies covalently finked to a reporter enzyme such as alkafine phosphatase or horseradish peroxidase, enzymes whose products are readily detected. When serum or other samples to be tested are placed in a plastic microtiter plate, the proteins adhere to the plastic surface and are immobilized. Any remaining absorbing areas of the well are then blocked by adding a nonantigenic protein such as bovine serum albumin. A solution of antibody covalently linked to a reporter enzyme is then added. The antibodies adhere to the immobilized antigen and these are themselves immobilized. Excess free antibody molecules are then removed by washing. The presence and quantity of bound antibody are then determined by adding the substrate for the reporter enzyme. 

Fig.4. Competition ELISAbetween antibody 10D5 and viologen dimer 2.Anmnber of antibody molecules are immobilized on the ELISA plate at lower concentrations of viologen dimer 2...

Antibody molecules are bivalent whilst antigens can be multivalent. The resultant combination may result in either small, soluble complexes, or large insoluble aggre tes, depending on the nature of the two molecules in the system. The following are examples of the reactions that can occur. 

The antibody molecule is based on a four-chain structure organized into three functional units (Fig. 7.2) (Padlan, 1993). Two of the units are identical and mediate binding to the antigen these regions are called the Fab (fragment antigen binding) arms of the antibody. The other unit, Fc... 

The goal of most protein modification or conjugation procedures is to create a stable product with good retention of the native state and activity. Ideally, any derivatization should result in a protein that performs exactly as it would in its unmodified form, but with the added functionality imparted by whatever is conjugated to it. Thus, an antibody molecule tagged with a fluorophore should retain its ability to bind to antigen and also have the added functionality of fluorescence. 

One of the best ways to ensure retention of activity in protein molecules is to avoid doing chemistry at the active center. The active center is that portion of the protein where ligand, antigen, or substrate binding occurs. In simpler terms, the active center (or active site) is that part that has specific interaction with another substance (Means and Feeney, 1971). For the preparation of enzyme derivatives, it is important to protect the site of catalysis where conversion of substrate to product happens. For instance, when working with antibody molecules, it is crucial to stay away from the two antigen binding sites. 

---